Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000008

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jan 3, 2017
Accepted (ET)
Feb 28, 2017 · 7:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJan 3, 2017P200$0.0572A19,626,115D
Common StockJan 4, 2017P200$0.0572A19,626,315D
Common StockJan 4, 2017P50$0.0498A19,626,365D
Common StockJan 4, 2017P150$0.05A19,626,515D
Common StockJan 4, 2017P200$0.05A19,626,715D
Common StockJan 4, 2017P950$0.05A19,627,665D
Common StockJan 4, 2017P50$0.0498A19,627,715D
Common StockJan 4, 2017P200$0.0544A19,627,915D
Common StockJan 4, 2017P200$0.0544A19,628,115D
Common StockJan 4, 2017P200$0.065A19,628,315D
Common StockJan 5, 2017P200$0.0585A19,628,515D
Common StockJan 5, 2017P200$0.0549A19,628,715D
Common StockJan 5, 2017P200$0.0499A19,628,915D
Common StockJan 5, 2017P200$0.0499A19,629,115D
Common StockJan 5, 2017P200$0.055A19,629,315D
Common StockJan 5, 2017P200$0.055A19,629,515D
Common StockJan 6, 2017P50$0.0496A19,629,565D
Common StockJan 6, 2017P150$0.0499A19,629,715D
Common StockJan 6, 2017P200$0.0499A19,629,915D
Common StockJan 9, 2017P200$0.05A19,630,115D
Common StockJan 9, 2017P200$0.0533A19,630,315D
Common StockJan 9, 2017P200$0.0529A19,630,515D
Common StockJan 9, 2017P200$0.052A19,630,715D
Common StockJan 10, 2017P200$0.0497A19,630,915D
Common StockJan 10, 2017P200$0.0492A19,631,115D
Common StockJan 10, 2017P200$0.0491A19,631,315D
Common StockJan 11, 2017P200$0.052A19,631,515D
Common StockJan 11, 2017P200$0.0477A19,631,715D
Common StockJan 11, 2017P1,000$0.0477A19,632,715D
Common StockJan 12, 2017P1,000$0.0449A19,633,715D

Table II — derivative securities

No Table II lines on this filing.